Meeting
2019 Gastrointestinal Cancers Symposium
Survival outcomes between surgery with adjuvant therapy compared to neoadjuvant therapy with surgery in stage I pancreatic adenocarcinoma: Results from a large national cancer database.
Authors
Samit Kumar Datta
Aurora Health Care, Milwaukee, WI
Samit Kumar Datta , Geoffrey Belini , Maharaj Singh , Wesley Allan Papenfuss , Federico Augusto Sanchez , Nalini Guda , James L. Weese , Aaron Chevinsky
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 335)
DOI
10.1200/JCO.2019.37.4_suppl.335
Abstract #
335
Poster Bd #
H13
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Survival impact of neoadjuvant therapy in resected pancreatic cancer.
First Author: Katelin Anne Mirkin
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A prospective translational study investigating the association of gut microbiome (GM) diversity with pathological complete response (pCR) after neoadjuvant treatment in early stage rectal and esophageal cancers.
First Author: Ronan Andrew Mc Laughlin
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Treatment sequencing for patients with localized duodenal and ampullary adenocarcinoma.
First Author: Abhishek Janardan
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Clinical relevance of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma who underwent surgery following neoadjuvant modified FOLFIRINOX.
First Author: So Heun Lee